CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

April 2, 2026 · PDUFA decision

RCKT PDUFA decision: a negative outcome, -19.6%

On April 2, 2026, RP-L201 — Rocket Pharmaceuticals, Inc. (Leukocyte Adhesion Defect - Type I) reached its PDUFA decision. The result was a negative outcome, and the stock moved -19.6% in the window around the event.

The move

$4.69
1d before
$3.77
Event day
$3.77
1d after
$3.62
5d after

Pre-catalyst setup

-1.4%
30-day run-up
9164%
30-day volatility
2.3×
volume spike